The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PPARG protein expression in advanced urothelial carcinoma and selection for response to FX-909, a first-in-class PPARG-targeting agent.
 
Evisa Gjini
Employment - Takeda (I)
Stock and Other Ownership Interests - Takeda (I)
 
William Motley
Employment - Flare Therapeutics; Lilly (I); RApport
Stock and Other Ownership Interests - Flare Therapeutics; Lilly (I); RApport
 
Adarsh Joshi
Employment - Flare Therapeutics; Takeda
Stock and Other Ownership Interests - Flare Therapeutics; Takeda
 
Bijal Kakrecha
Employment - Flare Therapeutics
Stock and Other Ownership Interests - Flare Therapeutics
Travel, Accommodations, Expenses - Flare Therapeutics
 
Jennifer Mertz
Employment - Flare Therapeutics
Stock and Other Ownership Interests - Flare Therapeutics
Research Funding - Novartis (I)
 
Kaylyn Williamson
Employment - Flare Therapeutics; Scorpion Therapeutics (I)
Stock and Other Ownership Interests - Flare Therapeutics; Scorpion Therapeutics (I)
 
Stefan Kirov
Employment - Flare Therapeutic
Stock and Other Ownership Interests - Amgen
 
Michaela Bowden
Employment - Flare Therapeutics
Leadership - Flare Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene; Flare Therapeutics